Celgene

News

Celgene under pressure as growth slows

Celgene has revealed disappointing Q3 results and scaled back forecasts for 2020, news which has caused its share price to plunge 18% yesterday.

News

Celgene axes gene silencing drug in Crohn's

Mongersen looks like being a $710m flop

News

FDA puts hold on AZ and Celgene immunotherapy trials

Regulator is exploring safety of immunotherapy combinations in blood cancer

News

NICE recommends Celgene pancreatic cancer drug

Abraxane finally gets NHS funding following price cut.

News

Celgene hopes device + drug can tackle aggressive brain tumo...

Novocure's Optune will be tested alongside investigational Celgene drug marizomib.

News

Natural killer cells are a type of lymphocytes which destroy cancer cells and other altered cells releasing cytotoxic granules.

Chinese CAR-T results offer hope of myeloma cure

This year’s ASCO conference has plenty of data from the CAR-T therapy contenders - but little known Chinese biotech Nanjing Biotech looks to have trumped all the established firms.

Celgene under pressure as growth slows

Celgene axes gene silencing drug in Crohn's

FDA puts hold on AZ and Celgene immunotherapy trials

NICE recommends Celgene pancreatic cancer drug

Celgene hopes device + drug can tackle aggressive brain tumo...

Chinese CAR-T results offer hope of myeloma cure

Delivering the right behavioural ingredients for the moment,...

How to meet your physicians where they are online

Celgene

Editor's Picks